ArticleHuman cell2021

Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.

Aditya K Panda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.